Examples of using Oxybate in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
withdrawal syndrome The discontinuation effects of sodium oxybate have not been systematically evaluated in controlled clinical trials.
The sodium oxybate or placebo equivalent dose was 6g/ day for the first 4 weeks
The rate of adverse reactions has increased when sodium oxybate is co-administered with tricyclic antidepressants.
Drug interaction studies in healthy adults demonstrated no pharmacokinetic interactions between sodium oxybate and protriptyline hydrochloride(an antidepressant),
Before increasing the sodium oxybate dose(see section 4.2),
Sodium oxybate was non-mutagenic and non-clastogenic in in vitro and in vivo assays.
In some patients, cataplexy may return at a higher frequency on cessation of sodium oxybate therapy, however this may be due to the normal variability of the disease.
There are no adequate data on the use of sodium oxybate during the first trimester of pregnancy.
A drug interaction study in healthy adults demonstrated no pharmacokinetic interactions between sodium oxybate(single dose of 4.5 g)
The use of haemodialysis and other forms of extracorporeal drug removal have not been studied in sodium oxybate overdose.
In some patients, cataplexy may return at a higher frequency on cessation of sodium oxybate therapy, however this may be due to the normal variability of the disease.
At sodium oxybate concentrations ranging from 3 to 300 μ g/ ml, less than 1% is bound to plasma proteins.
At sodium oxybate concentrations ranging from 3 to 300 µg/mL, less than 1% is bound to plasma proteins.
Drug interaction studies in healthy adults demonstrated no pharmacokinetic interactions between sodium oxybate and diclofenac.
Given the possibility of increasing the risk of respiratory depression, the concomitant use of benzodiazepines and sodium oxybate should be avoided.
If sodium oxybate and valproate are used concomitantly(see section 4.5), a decrease in sodium oxybate dose by 20% is recommended.
The use of haemodialysis and other forms of extracorporeal medicinal product removal have not been studied in sodium oxybate overdose.
The rate of adverse events have increased when sodium oxybate is co-administered with tricyclic antidepressants.
Sodium oxybate is considered to be unsafe in patients with porphyria because it has been shown to be porphyrogenic in animals or in vitro systems.
Patients with a previous history of a depressive illness and/or suicide attempt should be monitored especially carefully for the emergence of depressive symptoms while taking sodium oxybate.